Calvaruso V - Search Results

1

Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort.

Kondili LA, Quaranta MG, Cavalletto L, Calvaruso V, Ferrigno L, D'Ambrosio R, Simonelli I, Brancaccio G, Raimondo G, Brunetto MR, Zignego AL, Coppola C, Iannone A, Biliotti E, Verucchi G, Massari M, Licata A, Barbaro F, Persico M, Russo FP, Morisco F, Pompili M, Viganò M, Puoti M, Santantonio T, Villa E, Craxì A, Chemello L; PITER Collaborating Investigators. Kondili LA, et al. Among authors: calvaruso v. Dig Liver Dis. 2023 Jul;55(7):907-917. doi: 10.1016/j.dld.2023.01.153. Epub 2023 Feb 10. Dig Liver Dis. 2023. PMID: 36775720 Free article.

2

Critically ill patients with cirrhosis and low serum sodium.

Cholongitas E, Calvaruso V, Betrosian A, Senzolo M, Shaw S, O'Beirne J, Burroughs AK. Cholongitas E, et al. Among authors: calvaruso v. J Clin Gastroenterol. 2010 Aug;44(7):523-4; author reply 524-5. doi: 10.1097/MCG.0b013e3181d6b917. J Clin Gastroenterol. 2010. PMID: 20216426 Free article. No abstract available.

3

Histological subclassification of cirrhosis.

Germani G, Dhillon A, Andreana L, Calvaruso V, Manousou P, Isgró G, Burroughs AK. Germani G, et al. Among authors: calvaruso v. Hepatology. 2010 Aug;52(2):804-5. doi: 10.1002/hep.23655. Hepatology. 2010. PMID: 20593457 No abstract available.

4

Coagulation and fibrosis in chronic liver disease.

Calvaruso V, Maimone S, Gatt A, Tuddenham E, Thursz M, Pinzani M, Burroughs AK. Calvaruso V, et al. Gut. 2008 Dec;57(12):1722-7. doi: 10.1136/gut.2008.150748. Gut. 2008. PMID: 19022928

5

Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects.

Calvaruso V, Mazza M, Almasio PL. Calvaruso V, et al. Expert Opin Drug Saf. 2011 May;10(3):429-35. doi: 10.1517/14740338.2011.559161. Epub 2011 Feb 16. Expert Opin Drug Saf. 2011. PMID: 21323500 Review.

6

Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?

Calvaruso V. Calvaruso V. Gut. 2010 Jun;59(6):709-10. doi: 10.1136/gut.2009.201020. Gut. 2010. PMID: 20551451 No abstract available.

7

Corrigendum to 'Baveno VII - Renewing consensus in portal hypertension' [J Hepatol (2022) 959-974].

de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. de Franchis R, et al. J Hepatol. 2022 Jul;77(1):271. doi: 10.1016/j.jhep.2022.03.024. Epub 2022 Apr 14. J Hepatol. 2022. PMID: 35431106 No abstract available.

8

Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial.

Di Marco V, Almasio PL, Ferraro D, Calvaruso V, Alaimo G, Peralta S, Di Stefano R, Craxì A. Di Marco V, et al. Among authors: calvaruso v. J Hepatol. 2007 Oct;47(4):484-91. doi: 10.1016/j.jhep.2007.04.020. Epub 2007 Jun 27. J Hepatol. 2007. PMID: 17692985 Clinical Trial.

9

Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.

Petta S, Cammà C, DI Marco V, Calvaruso V, Enea M, Bronte F, Butera G, Cabibi D, Craxì A. Petta S, et al. Among authors: calvaruso v. Aliment Pharmacol Ther. 2009 Sep 15;30(6):603-13. doi: 10.1111/j.1365-2036.2009.04079.x. Epub 2009 Jun 25. Aliment Pharmacol Ther. 2009. PMID: 19563503 Free article.

10

Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.

Licata A, Calvaruso V, Cappello M, Craxì A, Almasio PL. Licata A, et al. Among authors: calvaruso v. Dig Liver Dis. 2010 Feb;42(2):143-8. doi: 10.1016/j.dld.2009.06.009. Epub 2009 Jul 21. Dig Liver Dis. 2010. PMID: 19625223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page